Test ID: FGF23
Fibroblast Growth Factor 23 (FGF23), Plasma
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
88662
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Diagnosing and monitoring oncogenic osteomalacia
Possible localization of occult neoplasms causing oncogenic osteomalacia
Diagnosing X-linked hypophosphatemia or autosomal dominant hypophosphatemic rickets
Diagnosing familial tumoral calcinosis with hyperphosphatemia
Predicting treatment response to calcitriol or vitamin D analogs in patients with renal failure
Method Name A short description of the method used to perform the test
Immunometric Enzyme Assay
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Fibroblast Growth Factor 23, P
Aliases Lists additional common names for a test, as an aid in searching
Autosomal Dominant Hypophosphatemic Rickets
Familial Tumoral Calcinosis with Hyperphosphatemia
Fibroblast Growth Factor 23 (FGF23)
Oncogenic Osteomalacia
Phosphatonin
X-Linked Hypophosphatemia
Familial Tumoral Calcinosis with Hyperphosphatemia
Fibroblast Growth Factor 23 (FGF23)
Oncogenic Osteomalacia
Phosphatonin
X-Linked Hypophosphatemia
External
link
PDF
document
Excel
document
Word
document